Emerson Electric Co.
NYSE:EMRIndustrial - Machinery
+$2.10 today
- Market cap
- $88.87B
- Beta
- 1.25
- P/E (TTM)
- 34.7
- EPS (TTM)
- $4.36
- Dividend yield
- 1.45%
Volume 2.90M
Average 2.88M
EMR Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
Emerson Electric Co.NYSE: EMR
Depreciation & Amortization · Q3 FY2026 · quarter ended Jun 2026
Depreciation & amortization growth accelerates
Q3 FY2026 depreciation & amortization of $377M rose 1.3% year over year, ahead of the -5.2% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 2.2% from the prior quarter. Over 3 fiscal years it compounded at +21.7% a year.
Context
- Depreciation & amortization amounted to 8.4% of revenue in FY2025, down 1.2 pp from a year earlier.
- Depreciation & amortization increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +1.3% holds above the trailing-twelve-month pace of -5.2%.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the income statement
- Latest · FY2025
- 1.52B USD
- Year-over-year change
- -10.1%
- 4-year CAGR
- +18.8%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-09-30 | 1.52B | -10.1% |
| FY2024 | 2024-09-30 | 1.69B | +60.7% |
| FY2023 | 2023-09-30 | 1.05B | +24.8% |
| FY2022 | 2022-09-30 | 842M | +10.5% |
| FY2021 | 2021-09-30 | 762M | — |
Depreciation & Amortization vs competitors
How EMR compares with its peers on the latest reported figures
- EMR's LTM Jun 2026 depreciation & amortization of $1.48B is the highest of the 8 companies compared; the peer median is $391.52M.
- Its year-over-year change of -5.2% is the lowest of 8, against a peer median of +6.7%.
- Depreciation & amortization amounts to 8.0% of revenue for EMR, versus a peer median of 4.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.48B | -5.2% | +21.7% | 8.0% | |
| LTM Jun 2026 | $1.18B | +23.1% | +1.8% | 3.9% | |
| LTM Jun 2026 | $937M | +3.3% | +4.6% | 4.4% | |
| LTM Jun 2026 | $775M | -0.3% | +6.5% | 3.1% | |
| LTM Sep 2026 | $391.52M | +6.7% | +7.3% | 4.6% | |
| LTM Jun 2026 | $322M | +0.2% | +10.8% | 3.6% | |
| LTM Jun 2026 | $231.9M | +33.6% | +34.0% | 4.8% | |
| LTM Jun 2026 | $212.7M | +8.8% | +19.9% | 5.9% | |
| Peer median (excluding EMR) | $391.52M | +6.7% | +7.3% | 4.4% | |
Competitors are the stored peer set for EMR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Sep 2021 | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 |
|---|---|---|---|---|---|
| Revenue | 12.93B | 13.8B | 15.17B | 17.49B | 18.02B |
| Cost of Revenue | 7.2B | 7.5B | 7.74B | 8.61B | 8.5B |
| Gross Profit | 5.73B | 6.31B | 7.43B | 8.89B | 9.52B |
| Gross Margin | 44.3% | 45.7% | 49.0% | 50.8% | 52.8% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 3.49B | 3.61B | 4.19B | 5.14B | 5.1B |
| Operating Expenses | 3.77B | 3.95B | 4.67B | 6.22B | 5.99B |
| Depreciation & Amortization | 762M | 842M | 1.05B | 1.69B | 1.52B |
| EBITDA | 2.69B | 3.5B | 4.22B | 4.03B | 4.84B |
| EBITDA Margin | 20.8% | 25.4% | 27.8% | 23.1% | 26.9% |
| Operating Income | 1.96B | 2.36B | 2.76B | 2.67B | 3.53B |
| Operating Margin | 15.1% | 17.1% | 18.2% | 15.2% | 19.6% |
| Interest Income | 12M | 34M | 268M | 234M | 150M |
| Interest Expense | 166M | 228M | 261M | 323M | 387M |
| Other Income / Expenses | (197M) | 76M | 144M | (646M) | (598M) |
| Income Before Tax | 1.76B | 2.43B | 2.9B | 2.02B | 2.93B |
| Pre-Tax Margin | 13.6% | 17.6% | 19.1% | 11.5% | 16.3% |
| Income Tax Expense | 346M | 549M | 642M | 415M | 696M |
| Net Income | 2.3B | 3.23B | 13.22B | 1.97B | 2.29B |
| Net Margin | 17.8% | 23.4% | 87.2% | 11.3% | 12.7% |
| EPS (Basic) | 3.85 | 4.63 | 3.75 | 3.44 | 4.07 |
| EPS (Diluted) | 3.83 | 4.60 | 3.73 | 3.43 | 4.04 |
| Weighted Avg Shares | 598.1M | 592.9M | 574.2M | 571.3M | 562.8M |
| Weighted Avg Shares (Diluted) | 601.8M | 592.9M | 577.3M | 574M | 566.7M |
Emerson Electric Co.
NYSE:EMR
Intrinsic Alpha fair value
Locked
Current Price
$162.00
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.